All Episodes
Lab to Lives — 95 episodes
The Emperor’s Naked And The Trial’s Still On w/ Dr. Grant Coren
What If The Real Blocker Is Coordination Not Data w/ Anastasia Christianson
Electrifying the Factory: Agentic AI For Faster Clinical Trials with Pamela Tenaerts
Why Big Pharma Feels Like A Financial Institution & Don't Pee on Medical Gloves with Anish Shindore
How Biotech Ideas Become Real Patient Impact w/ new co-hosts Alex and Dimitri
Dear Pharma, Your Patient Isn’t A KPI with Mark Duman
Audit Trails, RBQM, And Agentic AI Explained
Why Bringing The Trial To The Patient Beats Dragging Patients To Sites
Inside Sionna’s Bid To Normalize CFTR Function
AI Won’t Replace Writers, But Writers Who Use AI Will Outpace The Rest with Bilal Bham
From Grief To Global Advocacy For Clinical Research In Infectious Diseases with Christian John Lillis
Decoding Real-World Evidence: Beyond Clinical Trials with Manfred Stapff
Democratizing Drug Development Through AI-Native Platforms with Ilya Burkov
Incorruptible Evidence: Blockchain's Promise for Faster Drug Approvals w. Dominik Lysek
Revolutionizing Dentistry: AI and Research Innovation with Dr. Shervin Molayem
How early diagnostics of lung cancer can lead to better survival rates with Chris Wood
From Hopeless to High-Performing: Transforming Pharma Teams with Rajesh Anandan and Nechama Katan
Data Governance in the Age of Generative AI with Sebastian Andruszczak
Prevention Pays: How Technology Is Revolutionizing Mental Health with Eva Papadopoulou
Creating virtuous cycles in drug development with Rob Freishtat
Bridging Academia and Biotech: Creating Innovators of Tomorrow with Jonathon Hill
From Lab to Patient: Why Vector Design Makes or Breaks Cell Therapies with Alan Griffith
Tomorrow's Cures Are Hiding in Today's Patient Records with Vish Srivastava
Championing Diversity to Transform Clinical Research with Shelli Pavone
Revolutionizing Neurological Care: Andreas Forsland and Gregg Johns on Assistive Technology and Brain-Computer Interfaces
Revolutionizing Patient Recruitment in Clinical Trials: Unlocking Access and Accelerating Drug Development with Jill Pellegrino
Navigating the Shift: From SAS to R in Clinical Trials with Sunil Gupta
Enhancing Vendor Oversight and Communication Strategies in Clinical Trials with Jessica Cordes
Navigating Cell and Gene Therapy: Insights and Challenges with Dr. Bruce Levine
Reconnecting with Purpose: Transforming Job Satisfaction and Patient Care in Life Sciences with Jill Donahue
Revolutionizing Clinical Trials: The Promise of AI and Predictive Analytics with Vinodh Balaraman
Exploring Patient-Centric Innovations in Digestive and Women's Health with Ariadna Maso
Large Language Models in Clinical Trials with Eirini Schlosser
The Evolution of Clinical Trials Through Wearable Devices with Wessam Sonbol
Innovating Clinical Trial Design with Pierre Colin and Boaz Adler
Mastering the Art of Clinical Trial Partnerships: Insights from Jason Gubb on Outsourcing and Co-Creation
Breaking Barriers for Diversity in Clinical Trials with Sam Whitaker
“Adaptive Clinical Trial Design: Large-Scale Study Simulation to Design for Results with Boaz Adler
Towards a more Agile Vendor Qualification: A Discussion with Dele Babalola and Rani Naik
Becky Baggett on the Science and Strategy Behind Successful Clinical Trials
Designing Adaptable and Inclusive Labs for Biotech with Marilee Lloyd
Dr. Peter Small on Cough Science and the Impact of Acoustic Diagnostics
Exploring Generative AI in Life Sciences with Nechama Katan
How Cell and Gene Therapy Manufacturing is transforming Life Sciences with Jason Bock
Clinical Trial Supply is like an entire Galaxy with Ryan Keane
Harnessing the Power of Open-Source in Pharmacovigilance with Lionel Van Holle
Exploring the Intersection of Healthcare, Marketing, and the Power of Programmatic Advertising
Inventing New Endpoints with Richard Nkulikiyinka
Innovative Trial Design and Re-Imagined Endpoints with Richard Nkulikiyinka
From Dropout to Award-Winning Scientist: A Journey in Biotech with Pradeep Sacitharan
Decentralized Clinical Trials as Treatment Options with Ewa Lindqvist
Exploring the Impact of Open Source Software on the Pharmaceutical Industry with Katja Glass
The Ethical and Legal Challenges in Unapproved Drug Access: A Talk with Patti Zettler
Bridging the Gender Gap in Medical Research: The Potential of Wearable Technology
The Hidden Factors Behind Executive Retention in Life Sciences
Ravi Samavedam: On demand clean rooms for clinical trial supply
Leif Kuse: Nudging the industry towards innovation with group purchasing for biotechs
Tirrell Payton: Transforming the mindset in Life Sciences from Punitive to Innovative
Philip Russmeyer: Revolutionising clinical trials with true data anonymization
Sam Ewing: Virtual Wards & Digital Endpoints
Christian Born Djurhuus: Rethinking the waterfall approach of drug development
Simon Taylor: We need to deal with technological debt at clinical sites
Ole Henriksen: How health technology assessments transformed clinical development
Kimberly Tableman: Does true transformation in trials start with the clinical protocol?
André Chagwedera: Patients should decide which research is funded
Raj Indupuri: Data is the currency of the life sciences industry
Lars Rosendal: Leadership as the differentiating factor when drug development is uncertain
Rebecca Godfrey: How does a specialist transform into a leader?
Sophia Zilber: Getting to quality research from patient registries
Johan Lauritsen: There needs to be a simple apply button to participate in a clinical trial
Maya Zlatanova: Setting the clinical trial up for success by listening to the healthcare ecosystem
Dr. Daniel Fox: Transforming the balance between sites and sponsors
Brian D Smith: Transforming the debate on drug pricing vs. innovation
Graham Dutfield: As drugs become more precise, so needs the patent system
Kristin Carlsson Petri: How pharmacometrics modelling can augment and replace clinical trials
Temitope Keyes: Digitizing clinical trials from paper to decentralized trials
Dr. Elin Haf Davies: Benefits of designing trials for paediatric patients first
Andreas Dam: Transforming how pharma engages with patients and HCPs
Alexander Gray: Re-defining early-phase development to explore opportunities for assets
Dr. Jack Pearson and Sofie Askervall: Digital contraception and data science-based clinical research
Nechama Katan: Psychological safety as a prerequisite for solving wicked problems in life sciences
G.T. LaBorde: Arming clinicians with therapeutic options at the point of care
Savva Kerdemelidis and Nicholas Fiorenza: Applying crypto to fund clinical research
Andy Yates: Taking cannabis down from the high to solve unmet medical needs
Jon I. Bergsteinsson on MDR: Separating the data haves from the have-nots
Ivan Jarry: Transplanting the seamlessness of consumer health to clinical trials
Mark Wheeldon: Accelerating reaction time to data trends
Brian D Smith: Changing your DNA to pursue a novel business model
Philip Lyng Madsen: Re-thinking how patients can contribute to research
Matt Wilson: Transforming how patients benefit from population level research
Ulla Sofie Lønberg and Helle Hartnack on Bias: How behavioral trials can transform access to treatment
Jakob Juul Rasmussen: Zero cost technology - transforming how smaller companies oversee their assets
Willie Muehlhausen: Transformation in patient reported outcomes (eCOA, ePRO and DCT)
Adam Walker: Transformation in clinical data sources
Transformation in science, data and roles